American Association For Cancer Research
- Assets
- $241.9m
- Revenue
- $74.3m
- Investments
- $113.7m
- Employees
- 277
- Location
- Philadelphia, PA
- Founding
- 01/1965
- Data as of
- 12/2023
- EIN
- 23-6251648
Organization Overview
American Association For Cancer Research is located in Philadelphia, PA. The organization was established in 1965. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. As of 12/2023, American Association For Cancer Research employed 277 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. American Association For Cancer Research is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, American Association For Cancer Research generated $74.3m in total revenue. The organization has seen a slow decline revenue. Over the past 9 years, revenues have fallen by an average of (0.7%) each year. All expenses for the organization totaled $80.2m during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
PREVENT AND CURE CANCER THROUGH RESEARCH, EDUCATION, COMMUNICATION AND COLLABORATION.
Describe the Organization's Program Activity:
RESEARCH GRANTS, SCIENTIFIC AWARDS, FELLOWSHIPS AND CAREER DEVELOPMENT AWARDS.
ANNUAL MEETING AND SPECIAL CONFERENCES ATTENDED BY MEMBERS AND NON-MEMBERS FOR THE PRESENTATION OF SCIENTIFIC RESEARCH. ALSO INCLUDES EDUCATIONAL WORKSHOPS FOR TRAINING YOUNG INVESTIGATORS.
PUBLICATIONS - PRODUCTION & DISTRIBUTION OF THE JOURNALS: "CANCER RESEARCH", "MOLECULAR CANCER RESEARCH", "CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION", "CLINICAL CANCER RESEARCH", "MOLECULAR CANCER THERAPEUTICS", "CANCER PREVENTION RESEARCH", "CANCER DISCOVERY", "CANCER IMMUNOLOGY RESEARCH", "BLOOD CANCER DISCOVERY", AND "CANCER RESEARCH COMMUNICATIONS".
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Dr Lisa Coussens President (jan-Mar) | OfficerTrustee | 5 | $0 |
Dr Philip Greenberg President (apr-Dec) | OfficerTrustee | 5 | $0 |
Dr Philip Greenberg President-Elect (jan-Mar) | OfficerTrustee | 5 | $0 |
Dr Patricia Lorusso President-Elect (apr-Dec) | OfficerTrustee | 5 | $0 |
Dr David A Tuveson Past President (jan-Mar) | OfficerTrustee | 5 | $0 |
Dr Lisa Coussens Past President (apr-Dec) | OfficerTrustee | 5 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Freeman Audio Visual Services | 12/30/23 | $3,743,111 |
615 Chestnut Master Lease Lp Office Lease | 12/30/23 | $2,268,703 |
The Sheridan Press Publication Services | 12/30/23 | $964,314 |
Reaction Audio Visual Audio Visual Services | 12/30/23 | $1,507,195 |
Transportation Management Transportation Services | 12/30/23 | $907,748 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $15,552,359 |
| Government grants | $527,900 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $16,080,259 |
| Total Program Service Revenue | $58,133,068 |
| Investment income | $2,794,759 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $864,892 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | -$3,556,609 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $74,316,369 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $12,145,946 |
| Grants and other assistance to Foreign Orgs/Individuals | $1,416,000 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $1,414,496 |
| Compensation of current officers, directors, key employees. | $227,431 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $21,369,173 |
| Pension plan accruals and contributions | $1,650,778 |
| Other employee benefits | $2,875,236 |
| Payroll taxes | $1,528,035 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $484,952 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $404,254 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $1,222,904 |
| Fees for services: Other | $4,260,134 |
| Advertising and promotion | $2,899,800 |
| Office expenses | $0 |
| Information technology | $2,102,174 |
| Royalties | $0 |
| Occupancy | $2,429,482 |
| Travel | $1,940,470 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $7,085,233 |
| Interest | $0 |
| Payments to affiliates | $1,077,000 |
| Depreciation, depletion, and amortization | $194,173 |
| Insurance | $267,261 |
| All other expenses | $2,613,711 |
| Total functional expenses | $80,202,057 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $12,659,033 |
| Savings and temporary cash investments | $10,534,806 |
| Pledges and grants receivable | $22,506,959 |
| Accounts receivable, net | $2,459,930 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $4,512,664 |
| Net Land, buildings, and equipment | $154,051 |
| Investments—publicly traded securities | $64,058,890 |
| Investments—other securities | $113,716,156 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $11,347,096 |
| Total assets | $241,949,585 |
| Accounts payable and accrued expenses | $10,140,532 |
| Grants payable | $20,502,827 |
| Deferred revenue | $28,940,684 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $11,901,189 |
| Total liabilities | $71,485,232 |
| Net assets without donor restrictions | $156,067,190 |
| Net assets with donor restrictions | $14,397,163 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $241,949,585 |